3rd Annual Conference on Psychedelics and Psychedelic Medicine
We invite you to join us at the Westin Copley place in Boston for our 3rd Annual Conference on Psychedelics and Psychedelic Medicine conference.
This conference will provide up-to-date overviews and discussions of advances in the field of psychedelics and psychedelic-assisted therapies, with an emphasis on clinical studies and practice. Mechanisms of action including pharmacology, neuroscience, psychodynamic theory will be discussed, with a focus on specific clinical entities such as depression, PTSD, and addictions. Additional panel discussions and presentations will explore history, ethics, cultural issues, plant medicine, and many other relevant topics within the rapidly growing field of psychedelic medicine.
- Gain Knowledge, Insight, and Comprehension: Keep abreast of the latest developments in psychedelics and psychedelic-assisted therapies, focusing on clinical research and practical applications.
- Connect and Build Relationships: Engage with peers and specialists in the psychedelics industry, fostering networking opportunities and collaborations throughout the conference and beyond.
- Stay Current and Informed: Expand your understanding of the dynamic field of psychedelic medicine by participating in panel discussions and presentations that cover a wide range of topics, including history, ethics, culture, plant medicine, and other pertinent issues.
Super Early Bird Registration (on or before July 1, 2023): $650.00
Early Bird Registration (on or before August 15, 2023): $700.00
Regular Registration (after August 15, 2023): $750.00
Other Professionals or Trainees
Super Early Bird Registration (on or before July 1, 2023): $585.00
Early Bird Registration (on or before August 15, 2023) $630.00
Regular Registration (after August 15, 2023) $675.00
Residents & Medical Students: $150.00
***The deeply discounted Super Early Bird Registration rate is NON-REFUNDABLE and NON-TRANSFERABLE and will not be refunded under any circumstances.
*New* Virtual Registration
We are now adding a full virtual option to accommodate those who can not attend in person. Full more information and to register, please click the link below.
Psychedelics 2023: Virtual Registration: Click HERE
The conference syllabus is a printed book with all slide presentations and space to take notes adjacent to each slide.
Syllabus Book: $65
Ticketed Lunch Seminar (Optional):
Building a Psychedelic Assisted Therapy Practice - November 4, 2023
We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference.
A refund minus a $100.00 administrative fee will be issued for refund requests received by October 2, 2023. No refunds will be issued for refund requests made after October 2, 2023. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.
This program is intended for mental health practitioners including psychiatrists, psychiatric nurse practitioners, social workers and clinical psychologists.
By the end of this program, participants will be able to:
- Compare different models of psychedelic-assisted psychotherapy (eg, psycholytic vs psychedelic)
- Explain the neuropsychopharmacology of classical psychedelics as well as atypical psychedelics such as ketamine and empathogens such as MDMA
- Identify hypotheses for mechanisms of action of psychedelics on the brain, based on recent neuroimaging studies
- Critique contemporary medico-cultural issues within psychedelic research, including race-based structural biases and epistemic injustice
- Assess potential applications of psychedelic-assisted therapy in extra-psychiatric fields, such as within palliative care and spirituality, as well as within medicine, such as for pain and immunomodulation
Program Agenda coming soon!
Please check back at a later date for available room block information!
Franklin King, MD
Full Faculty List Coming Soon!
Accreditation Information is under review. Please check back for available CME!
David H. Rubin, MD, reviewer
Jane Pimental, MPH
Susan E. Sprich, PhD, psychologist reviewer
Franklin King, MD
In accord with the disclosure policy of McLean Hospital as well as guidelines set forth by the Accreditation Council on Continuing Medical Education, all people in control of educational content, including speakers, course directors, planners, and reviewers, have been asked to disclose all relevant financial relationships with commercial interests of both themselves and their spouses/partners over the past 12 months, as defined below:
The ACCME defines an "Ineligible company" as "those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients." For more information, visit accme.org/standards
Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.
Mitigation of Financial Relationships
All financial relationships are reviewed to determine which ones are relevant, and then measures are taken to mitigate all relevant financial relationships and ensure that they do not insert commercial bias into the content of the education.
The following planners, speakers, content reviewers, and others in control of educational content have reported financial relationships with ineligible companies over the past 24 months. Measures have been taken to mitigate the impact of these financial relationships on the educational content and ensure that they do not insert commercial bias into the content of this education
Susan Sprich, PhD (Psychologist Reviewer)
Royalties (Co-Author): Oxford University Press
Royalties (Co-Edited Book): Springer
Honoraria (Associate Editors): Association for Behavioral and Cognitive Therapies (ABCT)
All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have, on behalf of themselves and their spouse or partner, reported no financial relationships related to the content of this activity.
Optimal System Configuration
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher
Windows PC:500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh: Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit